Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 3Terminated 2Active not recruiting 2

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Head & Neck 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 19Colorectal Neoplasms 18Breast Neoplasms 17Lung Neoplasms 15Colonic Neoplasms 10Head and Neck Neoplasms 9Rectal Neoplasms 7Glioblastoma 5Prostatic Neoplasms 4Precancerous Conditions 4Mouth Neoplasms 4Esophageal Neoplasms 4Central Nervous System Neoplasms 4Adenomatous Polyposis Coli 4Uterine Cervical Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 3Sarcoma 3Neuroblastoma 3Neoplasms 3Liver Neoplasms 3Gliosarcoma 3Glioma 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Smoking 2Salivary Gland Neoplasms 2Pancreatic Neoplasms 2Oropharyngeal Neoplasms 2Nasopharyngeal Neoplasms 2Multiple Myeloma 2

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79Bevacizumab 75pembrolizumab 74Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Neoplasms × Celecoxib × Clear all
NCT00081848 2017-07-02

Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
12 enrolled
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Neoplasms

NCT00581971 2013-04-25

RAD0201

University of Alabama at Birmingham

Phase 1/2 Completed
30 enrolled 8 charts
Head & Neck

Head and Neck Neoplasms, Neoplasms

NCT00165451 2011-07-07

A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer

Dana-Farber Cancer Institute

Phase 2 Completed
20 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡